Nucleoside diphosphate kinase B
AltitudeomicsDB
Protein Official symbol |
NME1-NME2 |
Aliases |
NME2 NM23B |
Chromosomal Location |
17 |
Length |
152 |
Uniprot ID |
P22392 |
EC number |
2.7.4.6; 2.7.13.3 |
Protein family Information(Pfam) |
PF00334; |
PDB id |
1NSK;1NUE;3BBB;3BBC;3BBF; |
InterPro ID |
IPR034907;IPR036850;IPR001564;IPR023005; |
dbSNP |
None |
AltitudeomicsDB
Protein 1 |
Protein 2 |
Combine Score |
DUT |
DTYMK |
0.994 |
ITPA |
GUK1 |
0.955 |
NUDT16 |
ITPA |
0.955 |
NME1-NME2 |
CMPK2 |
0.949 |
NME1-NME2 |
DTYMK |
0.946 |
NTPCR |
ENTPD2 |
0.93 |
DCTPP1 |
CMPK2 |
0.927 |
PNPT1 |
CMPK2 |
0.927 |
NME1-NME2 |
GUK1 |
0.923 |
ITPA |
NUDT2 |
0.923 |
PNPT1 |
NME1-NME2 |
0.921 |
NME1-NME2 |
ITPA |
0.919 |
NME1-NME2 |
DUT |
0.919 |
HDDC3 |
GUK1 |
0.918 |
PNPT1 |
GUK1 |
0.916 |
NME1-NME2 |
AK3 |
0.915 |
DUT |
ITPA |
0.914 |
PNPT1 |
AK3 |
0.912 |
PNPT1 |
ENTPD2 |
0.911 |
PNPT1 |
HDDC3 |
0.91 |
NUDT16 |
NME1-NME2 |
0.907 |
AK3 |
ENTPD2 |
0.906 |
NME1-NME2 |
NUDT2 |
0.906 |
HDDC3 |
NME1-NME2 |
0.905 |
PNPT1 |
NTPCR |
0.905 |
NME1-NME2 |
DCTPP1 |
0.903 |
NME1-NME2 |
NTPCR |
0.902 |
DTYMK |
CMPK2 |
0.902 |
NME1-NME2 |
ENTPD2 |
0.902 |
AK3 |
NTPCR |
0.901 |
Gene Ontology Semantic Similarity
Download Tab separated file
# |
1854 (DUT) |
3704 (ITPA) |
131870 (NUDT16) |
4831 (NME1-NME2) |
84284 (NTPCR) |
79077 (DCTPP1) |
87178 (PNPT1) |
374659 (HDDC3) |
50808 (AK3) |
1841 (DTYMK) |
2987 (GUK1) |
129607 (CMPK2) |
954 (ENTPD2) |
318 (NUDT2) |
1854 (DUT)
|
1.00
|
0.69
|
0.58
|
0.52
|
1.00
|
0.86
|
0.65
|
1.00
|
0.50
|
0.12
|
0.12
|
0.12
|
0.66
|
0.60
|
3704 (ITPA)
|
0.69
|
1.00
|
0.50
|
0.29
|
0.30
|
0.86
|
0.30
|
0.82
|
0.33
|
0.13
|
0.14
|
0.13
|
0.75
|
0.61
|
131870 (NUDT16)
|
0.58
|
0.50
|
1.00
|
0.43
|
0.88
|
0.57
|
0.44
|
0.82
|
0.29
|
0.10
|
0.14
|
0.10
|
0.75
|
0.39
|
4831 (NME1-NME2)
|
0.52
|
0.29
|
0.43
|
1.00
|
0.75
|
0.43
|
0.56
|
1.00
|
0.59
|
0.47
|
0.74
|
0.47
|
0.15
|
0.39
|
84284 (NTPCR)
|
1.00
|
0.30
|
0.88
|
0.75
|
1.00
|
0.37
|
1.00
|
0.37
|
0.37
|
0.08
|
0.08
|
0.08
|
0.08
|
0.37
|
79077 (DCTPP1)
|
0.86
|
0.86
|
0.57
|
0.43
|
0.37
|
1.00
|
0.42
|
1.00
|
0.51
|
0.13
|
0.14
|
0.13
|
0.75
|
0.68
|
87178 (PNPT1)
|
0.65
|
0.30
|
0.44
|
0.56
|
1.00
|
0.42
|
1.00
|
1.00
|
0.47
|
0.24
|
0.41
|
0.24
|
0.17
|
0.38
|
374659 (HDDC3)
|
1.00
|
0.82
|
0.82
|
1.00
|
0.37
|
1.00
|
1.00
|
1.00
|
1.00
|
0.13
|
0.12
|
0.13
|
0.14
|
1.00
|
50808 (AK3)
|
0.50
|
0.33
|
0.29
|
0.59
|
0.37
|
0.51
|
0.47
|
1.00
|
1.00
|
0.67
|
0.74
|
0.64
|
0.15
|
0.47
|
1841 (DTYMK)
|
0.12
|
0.13
|
0.10
|
0.47
|
0.08
|
0.13
|
0.24
|
0.13
|
0.67
|
1.00
|
0.82
|
0.94
|
0.15
|
0.12
|
2987 (GUK1)
|
0.12
|
0.14
|
0.14
|
0.74
|
0.08
|
0.14
|
0.41
|
0.12
|
0.74
|
0.82
|
1.00
|
0.82
|
0.14
|
0.12
|
129607 (CMPK2)
|
0.12
|
0.13
|
0.10
|
0.47
|
0.08
|
0.13
|
0.24
|
0.13
|
0.64
|
0.94
|
0.82
|
1.00
|
0.15
|
0.12
|
954 (ENTPD2)
|
0.66
|
0.75
|
0.75
|
0.15
|
0.08
|
0.75
|
0.17
|
0.14
|
0.15
|
0.15
|
0.14
|
0.15
|
1.00
|
0.59
|
318 (NUDT2)
|
0.60
|
0.61
|
0.39
|
0.39
|
0.37
|
0.68
|
0.38
|
1.00
|
0.47
|
0.12
|
0.12
|
0.12
|
0.59
|
1.00
|
Association with High Altitude
Protein Official symbol |
Source Organism |
Tissue of Expression |
Level of hypoxia |
Altitude |
Duration of experiment |
Level of expression |
Fold change |
Experiment details |
geographical location |
ethnicity of the patients |
Control group |
Control (Fold change) |
Reference (PMID) |
NME1-NME2 |
Rat |
Plasma |
- |
7620 m |
6 hours |
upregulated |
1.61 |
2-DE |
Northern indo-australian plate |
Sprague-dawley rats |
1 |
Male SD rats weighing 220g |
24842778 |
NME1-NME2 |
Rat |
Plasma |
- |
7620 m |
12 hours |
upregulated |
1.89 |
2-DE |
Northern indo-australian plate |
Sprague-dawley rats |
1 |
Male SD rats weighing 220g |
24842778 |
NME1-NME2 |
Rat |
Plasma |
- |
7620 m |
24 hours |
upregulated |
1.35 |
2-DE |
Northern indo-australian plate |
Sprague-dawley rats |
1 |
Male SD rats weighing 220g |
24842778 |
Gene Ontology
ID |
GO ID |
GO Term |
GO Type |
4831 |
GO:0006165 |
nucleoside diphosphate phosphorylation |
GOTERM_BP_DIRECT |
4831 |
GO:0006241 |
CTP biosynthetic process |
GOTERM_BP_DIRECT |
4831 |
GO:0007229 |
integrin-mediated signaling pathway |
GOTERM_BP_DIRECT |
4831 |
GO:0005737 |
cytoplasm |
GOTERM_CC_DIRECT |
4831 |
GO:0070062 |
extracellular exosome |
GOTERM_CC_DIRECT |
4831 |
GO:0006351 |
transcription |
GOTERM_BP_DIRECT |
4831 |
GO:0046777 |
protein autophosphorylation |
GOTERM_BP_DIRECT |
4831 |
GO:0051259 |
protein oligomerization |
GOTERM_BP_DIRECT |
4831 |
GO:0003677 |
DNA binding |
GOTERM_MF_DIRECT |
4831 |
GO:0005524 |
ATP binding |
GOTERM_MF_DIRECT |
4831 |
GO:0008144 |
poly |
GOTERM_MF_DIRECT |
4831 |
GO:0005634 |
nucleus |
GOTERM_CC_DIRECT |
4831 |
GO:0004674 |
protein serine/threonine kinase activity |
GOTERM_MF_DIRECT |
4831 |
GO:0006355 |
regulation of transcription |
GOTERM_BP_DIRECT |
4831 |
GO:0001726 |
ruffle |
GOTERM_CC_DIRECT |
4831 |
GO:0050679 |
positive regulation of epithelial cell proliferation |
GOTERM_BP_DIRECT |
4831 |
GO:0007155 |
cell adhesion |
GOTERM_BP_DIRECT |
4831 |
GO:0010976 |
positive regulation of neuron projection development |
GOTERM_BP_DIRECT |
4831 |
GO:0031966 |
mitochondrial membrane |
GOTERM_CC_DIRECT |
4831 |
GO:0030819 |
positive regulation of cAMP biosynthetic process |
GOTERM_BP_DIRECT |
4831 |
GO:0005882 |
intermediate filament |
GOTERM_CC_DIRECT |
4831 |
GO:0006163 |
purine nucleotide metabolic process |
GOTERM_BP_DIRECT |
4831 |
GO:0045682 |
regulation of epidermis development |
GOTERM_BP_DIRECT |
4831 |
GO:0005925 |
focal adhesion |
GOTERM_CC_DIRECT |
4831 |
GO:0030027 |
lamellipodium |
GOTERM_CC_DIRECT |
4831 |
GO:0071398 |
cellular response to fatty acid |
GOTERM_BP_DIRECT |
4831 |
GO:0003700 |
transcription factor activity |
GOTERM_MF_DIRECT |
4831 |
GO:0005829 |
cytosol |
GOTERM_CC_DIRECT |
4831 |
GO:0015949 |
nucleobase-containing small molecule interconversion |
GOTERM_BP_DIRECT |
4831 |
GO:0043066 |
negative regulation of apoptotic process |
GOTERM_BP_DIRECT |
4831 |
GO:0060416 |
response to growth hormone |
GOTERM_BP_DIRECT |
4831 |
GO:0004673 |
protein kinase activity |
GOTERM_MF_DIRECT |
4831 |
GO:0005504 |
retinoid binding |
GOTERM_MF_DIRECT |
4831 |
GO:0009142 |
nucleoside triphosphate biosynthetic process |
GOTERM_BP_DIRECT |
4831 |
GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
GOTERM_BP_DIRECT |
4831 |
GO:0004550 |
deoxyribonuclease activity |
GOTERM_MF_DIRECT |
4831 |
GO:0019899 |
enzyme binding |
GOTERM_MF_DIRECT |
4831 |
GO:0046872 |
metal ion binding |
GOTERM_MF_DIRECT |
4831 |
GO:0071944 |
cell periphery |
GOTERM_CC_DIRECT |
4831 |
GO:0006220 |
pyrimidine nucleotide metabolic process |
GOTERM_BP_DIRECT |
4831 |
GO:0034599 |
cellular response to oxidative stress |
GOTERM_BP_DIRECT |
4831 |
GO:0002762 |
negative regulation of myeloid leukocyte differentiation |
GOTERM_BP_DIRECT |
4831 |
GO:0045618 |
positive regulation of keratinocyte differentiation |
GOTERM_BP_DIRECT |
4831 |
GO:0071333 |
cellular response to glucose stimulus |
GOTERM_BP_DIRECT |
4831 |
GO:0043209 |
myelin sheath |
GOTERM_CC_DIRECT |
4831 |
GO:0019215 |
glyoxalase III activity |
GOTERM_MF_DIRECT |
4831 |
GO:0006183 |
GTP biosynthetic process |
GOTERM_BP_DIRECT |
4831 |
GO:0006228 |
UTP biosynthetic process |
GOTERM_BP_DIRECT |
4831 |
GO:0018106 |
peptidyl-histidine phosphorylation |
GOTERM_BP_DIRECT |
4831 |
GO:0005515 |
protein binding |
GOTERM_MF_DIRECT |
4831 |
GO:0048471 |
perinuclear region of cytoplasm |
GOTERM_CC_DIRECT |
Pathways
Human Entrez ID |
KEGG ID |
KEGG Term |
4831 |
hsa00240 |
Pyrimidine metabolism |
4831 |
hsa00230 |
Purine metabolism |
4831 |
hsa01130 |
Biosynthesis of antibiotics |
4831 |
hsa01100 |
Metabolic pathways |
Association with Disease
Protein Official Symbol |
Human Entrez ID |
Disease Name |
Disease Id |
Disease Semantic Type |
Semantic score |
DSI |
DPI |
Disease Type |
NME2 |
4831 |
Degenerative polyarthritis |
C0029408 |
Disease or Syndrome |
0.3 |
0.604 |
0.552 |
disease |
NME2 |
4831 |
ovarian neoplasm |
C0919267 |
Neoplastic Process |
0.31 |
0.604 |
0.552 |
disease |
NME2 |
4831 |
Colorectal Carcinoma |
C0009402 |
Neoplastic Process |
0.31 |
0.604 |
0.552 |
disease |
NME2 |
4831 |
Colorectal Cancer |
C1527249 |
Neoplastic Process |
0.31 |
0.604 |
0.552 |
disease |
NME2 |
4831 |
Mesothelioma |
C0025500 |
Neoplastic Process |
0.3 |
0.604 |
0.552 |
disease |
NME2 |
4831 |
Osteoarthrosis Deformans |
C0086743 |
Disease or Syndrome |
0.3 |
0.604 |
0.552 |
disease |
NME2 |
4831 |
Colorectal Neoplasms |
C0009404 |
Neoplastic Process |
0.3 |
0.604 |
0.552 |
group |
NME2 |
4831 |
Malignant neoplasm of ovary |
C1140680 |
Neoplastic Process |
0.32 |
0.604 |
0.552 |
disease |
Association with Drug
Protein Official Symbol |
Human Entrez ID |
drug_claim_primary_name |
drug_name |
drug_chembl_id |
interaction_types |
NME2 |
4831 |
PROGESTERONE |
PROGESTERONE |
CHEMBL103 |
None |